Alewijnse AE[au] - Search Results

Year	Number of Results
1995	1
1996	2
1997	1
1998	5
2000	2
2001	1
2002	1
2004	1
2006	4
2007	5
2008	5
2009	8
2010	4
2011	3
2012	3
2014	2
2016	1
2024	0

1

Michel MC, Mulders AC, Jongsma M, Alewijnse AE, Peters SL. Michel MC, et al. Among authors: alewijnse ae. Acta Paediatr. 2007 Apr;96(455):44-8. doi: 10.1111/j.1651-2227.2007.00207.x. Acta Paediatr. 2007. PMID: 17391441 Review.

2

Sphingosine-1-phosphate signaling in the cardiovascular system.

Peters SL, Alewijnse AE. Peters SL, et al. Among authors: alewijnse ae. Curr Opin Pharmacol. 2007 Apr;7(2):186-92. doi: 10.1016/j.coph.2006.09.008. Epub 2007 Feb 5. Curr Opin Pharmacol. 2007. PMID: 17280869 Review.

3

Agonist-independent regulation of constitutively active G-protein-coupled receptors.

Leurs R, Smit MJ, Alewijnse AE, Timmerman H. Leurs R, et al. Among authors: alewijnse ae. Trends Biochem Sci. 1998 Nov;23(11):418-22. doi: 10.1016/s0968-0004(98)01287-0. Trends Biochem Sci. 1998. PMID: 9852759 Review.

4

Sphingosine-1-phosphate receptors: zooming in on ligand-induced intracellular trafficking and its functional implications.

Verzijl D, Peters SL, Alewijnse AE. Verzijl D, et al. Among authors: alewijnse ae. Mol Cells. 2010 Feb 28;29(2):99-104. doi: 10.1007/s10059-010-0041-z. Epub 2010 Jan 29. Mol Cells. 2010. PMID: 20127285 Free article. Review.

5

Cardiovascular effects of sphingosine-1-phosphate and other sphingomyelin metabolites.

Alewijnse AE, Peters SL, Michel MC. Alewijnse AE, et al. Br J Pharmacol. 2004 Nov;143(6):666-84. doi: 10.1038/sj.bjp.0705934. Epub 2004 Oct 25. Br J Pharmacol. 2004. PMID: 15504747 Free PMC article. Review.

6

Sphingolipid signalling in the cardiovascular system: good, bad or both?

Alewijnse AE, Peters SL. Alewijnse AE, et al. Eur J Pharmacol. 2008 May 13;585(2-3):292-302. doi: 10.1016/j.ejphar.2008.02.089. Epub 2008 Mar 15. Eur J Pharmacol. 2008. PMID: 18420192 Review.

7

Regulation of G protein-coupled receptor signalling: focus on the cardiovascular system and regulator of G protein signalling proteins.

Hendriks-Balk MC, Peters SL, Michel MC, Alewijnse AE. Hendriks-Balk MC, et al. Among authors: alewijnse ae. Eur J Pharmacol. 2008 May 13;585(2-3):278-91. doi: 10.1016/j.ejphar.2008.02.088. Epub 2008 Mar 15. Eur J Pharmacol. 2008. PMID: 18410914 Review.

8

Sphingolipids and the orchestration of endothelium-derived vasoactive factors: when endothelial function demands greasing.

Spijkers LJ, Alewijnse AE, Peters SL. Spijkers LJ, et al. Among authors: alewijnse ae. Mol Cells. 2010 Feb 28;29(2):105-11. doi: 10.1007/s10059-010-0042-y. Epub 2010 Jan 29. Mol Cells. 2010. PMID: 20127284 Free article. Review.

9

Pitfalls in the normalization of real-time polymerase chain reaction data.

Hendriks-Balk MC, Michel MC, Alewijnse AE. Hendriks-Balk MC, et al. Among authors: alewijnse ae. Basic Res Cardiol. 2007 May;102(3):195-7. doi: 10.1007/s00395-007-0649-0. Basic Res Cardiol. 2007. PMID: 17370033 Free PMC article.

10

Constitutive activity of G protein coupled receptors and drug action.

Leurs R, Rodriguez Pena MS, Bakker RA, Alewijnse AE, Timmerman H. Leurs R, et al. Among authors: alewijnse ae. Pharm Acta Helv. 2000 Mar;74(2-3):327-31. doi: 10.1016/s0031-6865(99)00042-4. Pharm Acta Helv. 2000. PMID: 10812977 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

46 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Results by year